What question did this study set out to answer?

Evaluate the impact of AAV gene therapy on bleeding rates and factor IX expression in hemophilia B.

December 8, 2025BloodOpen Access

AAV gene therapy in hemophilia B shows robust bleeding reduction and variable factor IX expression: A bayesian meta-analysis of randomized controlled trials

View Full Paper

Ask AI

Bookmark

Authors

DPDevender PathakNovartis (Switzerland)VVVenkata Dileep Kumar VeldiKalam Institute of Health Technology ADA. N. DasMayo Clinic in Florida

Discussion

Member takes

Implication

Bayesian meta-analysis demonstrates gene therapy reduces bleeding rates in hemophilia B, suggesting personalized dosing and vector strategies are needed.

Key Points

Evaluate the impact of AAV gene therapy on bleeding rates and factor IX expression in hemophilia B.
Conducted a Bayesian meta-analysis on data from trials HOPE-B, BENEGENE-2, and 101HEMB01/02.
Compared gene therapy with AAV vectors to baseline or prophylactic treatment in hemophilia B patients.
Utilized a random-effects model within a hierarchical Bayesian framework.
Pooled analysis showed significant reduction in annualized bleeding rate (ABR) with positive rate ratio values favoring gene therapy.
Mean FIX activity levels revealed substantial variability across trials, influenced by vector and dosing differences.
Pooled log relative risk for achieving zero bleeds indicated potential benefits, though with uncertain clinical significance.

Cite This Study

Pathak et al. (2025) studied this question.

synapsesocial.com/papers/69362f6e4fa91c937236e120 https://doi.org/10.1182/blood-2025-4852

View Full Paper

Ask AI

Bookmark

Implication

Bayesian meta-analysis demonstrates gene therapy reduces bleeding rates in hemophilia B, suggesting personalized dosing and vector strategies are needed.

AAV gene therapy in hemophilia B shows robust bleeding reduction and variable factor IX expression: A bayesian meta-analysis of randomized controlled trials

Discussion

Member takes

Implication

Key Points

Cite This Study

AAV gene therapy in hemophilia B shows robust bleeding reduction and variable factor IX expression: A bayesian meta-analysis of randomized controlled trials

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider